Global Neurological Biomarkers Market 2016-2020

  • Published: Sep 2016
  • Pages: 68
  • SKU: IRTNTR10239

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

This market study identifies vendors such as QIAGEN, Myriad RBM, Proteome Sciences, and Thermo Fisher Scientific as the key players in the global neurological biomarkers market. This research reports also presents segmentations based on indication (ASD, AD, PD, and MS), application (genomics, proteomics, metabolomics, and imaging), end-users (hospitals and diagnostic and research laboratories), and geography (the Americas, APAC, and EMEA).

Neurological biomarkers market forecast

Technavio’s market research predicts that the global neurological biomarkers market will grow progressively at an impressive CAGR of more than 15% by 2020. The increasing number of low-cost clinical trials in developing countries will help the market to grow during the forecast period. The potential clinical advantages of disease-particular biomarkers will result in faster and accurate disease analysis, and potential diminishment in terms of clinical medication trials, which would, in turn, accelerate drug improvement.

Since both the FDA (Food and Drug Administration) and the EMA (European Medicines Agency) recognize the essential role of biomarkers in the overall medication improvement process, it will lead to the formation of an ethical committee between the developed and developing countries to provide a standard, effective, and consistent ethical guidance. The establishment of an ethical committee will help to avoid the exploitation of participants involved in clinical trials through the regular monitoring of the FDA along with the participating countries for effective low-cost clinical trials in developing countries.

Neurological biomarkers market regions 

Market analysts predict that the Americas will dominate the market and post a CAGR of approximately 9% during the forecast period. Increasing funding from different societies and private organizations towards the extensive research on drug development for various diseases such as Alzheimer's disease, Parkinson’s disease, Autism spectrum disorder, and multiple sclerosis will be one of the primary growth drivers for the market in this region. Additionally, factors such as a rise in the number of clinical trials, hospitals, and labs in new potential areas, such as Mexico and Brazil, will lead to the steady growth of this market in the Americas.

Neurological biomarkers market scope: Competitive landscape and key vendors

There is intense competition in the market due to the presence of many established players and emerging companies. The vendors will be engaging in robust R&D to gain time approvals for new biomarkers and to improve the detection capability of neuro biomarkers, which will, in turn,  aid in the growth of the market during the forecast period.

Leading vendors in the neurological biomarkers market

  • Myriad RBM
  • Proteome Sciences
  • Thermo Fisher Scientific

Neurological biomarkers market based on the indication

  • Alzheimer's disease
  • Parkinson’s disease
  • Autism spectrum disorder
  • Multiple sclerosis

During 2015, the Autism spectrum disorder (ASD) segment dominated the market by accounting for around 55% of the total market share. The introduction of new and effective biomarkers, such as the ASD1, will help to augment the adoption of neurological biomarkers for the effective identification of ASD.

Neurological biomarkers market demand based on application

  • Genomics
  • Proteomics
  • Metabolomics
  • Imaging

Based on the neurological biomarkers industry analysis, the genomic biomarkers segment dominated the market by accounting for around 44% of the total market share. Advancements in high-throughput sequencing, single nucleotide polymorphism (SNP) chips, multiplexed, and various quality neurological biomarker measures will lead to the increase in the neurological biomarkers market size during the forecasted period.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global neurological biomarkers market?
  • What are the key market trends impacting the global neurological biomarkers market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global neurological biomarkers market?
  • What are the market opportunities and threats faced by the vendors in the global neurological biomarkers market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global neurological biomarkers market?

Technavio also offers customization on reports based on specific client requirement.

Related reports




Read More Read Less

Table of Content

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Biomarker assays kits

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis:

PART 06: Market segmentation by indication

  • AD
  • PD
  • ASD
  • MS

PART 07: Market segmentation by application

  • Genomics-based biomarkers
  • Proteomics-based biomarkers
  • Metabolomics-based biomarkers
  • Imaging-based biomarkers
  • Emerging application areas

PART 08: Market segmentation by services

  • Services

PART 09: Market segmentation by end-user

  • Hospitals
  • Diagnostic and research laboratories

PART 10: Geographical segmentation

  • Neurological biomarkers market in Americas
  • Neurological biomarkers market in EMEA
  • Neurological biomarkers market in APAC

PART 11: Market drivers

  • Increasing low-cost clinical trials in developing countries
  • Growing personalized medicine for neurological disorders
  • Increasing focus toward drug discovery applications

PART 12: Impact of drivers

PART 13: Market challenges

  • Unmet market needs of effective validation of biomarkers
  • Reproducibility of biomarkers and tests leading to discrepancies
  • Delay in market launch

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Integrated biology approach will be the key focus area
  • Development of novel radiotracers for neuro biomarkers that aid diagnostic and clinical applications for diseases
  • Evolution of miRNA

PART 16: Vendor landscape

  • Competitive scenario

PART 17: Key vendor analysis

  • Geographic presence — Key vendor analysis
  • Myriad RBM
  • Proteome Sciences
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>